They demonstrated the proportion of TIM3+FOXP3+ Tregs, which could potently suppress IFN‐γ and TNF‐α inflammation from Teffs by producing high IL‐10 and TGF‐β, was significantly decreased in patients with RA. The gene discussed is FOXP3; the disease is rheumatoid arthritis.